Comparison

LSKL, Inhibitor of Thrombospondin TSP-1 European Partner

Item no. TMO-T7377-10mg
Manufacturer TargetMol
CASRN 283609-79-0
Amount 10mg
Category
Type Molecules
Specific against other
Smiles CC(C)CC(N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(N)=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 283609-79-0, LSKL, Inhibitor of Thrombospondin TSP-1
Available
Short Description
LSKL, Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide, inhibits thrombospondin (TSP-1) activation of TGF-β.
Shipping
cool pack
Storage
-20°
Target names or alias
LSKL, Inhibitor of Thrombospondin TSP-1
Molecular Weight
458, 6
Pathway
Stem Cells
Target
TGF-beta/Smad

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mg
Available: In stock
available

Delivery expected until 9/20/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?